WT
GILD icon

Wilmington Trust’s Gilead Sciences GILD Stock Holding History

Wilmington Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$15M Buy
180,974
+33,223
+22% +$2.59M 0.25% 74
2014
Q1 		$10.5M Buy
147,751
+9,175
+7% +$720K 0.18% 94
2013
Q4 		$10.4M Buy
138,576
+3,304
+2% +$230K 0.18% 96
2013
Q3 		$8.51M Sell
135,272
-1,058
-0.8% -$63.2K 0.15% 106
2013
Q2 		$6.99M Buy
+136,330
New +$7.11M 0.14% 120

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wilmington Trust's GILD Position: Q2 2014 in Review

Wilmington Trust increased its Gilead Sciences (GILD) stake by 22% in Q2 2014, buying an estimated $2.59M and bringing the position to 180,974 shares worth $15M. The position accounts for 0.25% of the portfolio, ranked #74.

Wilmington Trust first reported a position in GILD in Q2 2013 and has held it in 5 quarters since. 1,263 funds tracked by Wall St. Rank hold GILD as of Q2 2014.

  • Wilmington Trust held 180,974 shares of Gilead Sciences worth $15M as of Q2 2014.
  • Wilmington Trust bought 33,223 Gilead Sciences shares in Q2 2014, an estimated $2.59M.
  • Gilead Sciences made up 0.25% of Wilmington Trust's portfolio in Q2 2014, its #74 holding.
  • Wilmington Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 5 quarters since.
  • 1,263 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.